112 / 236
Atul Ltd | Annual Report 2016-17
(
`
cr)
Note 5 Non-current investments
(continued)
Face
value
As at
March 31, 2017
As at
March 31, 2016
As at
April 01, 2015
Number
of shares
Number
of shares
Number
of shares
b) Investment in Preference shares (fully
paid-up)
Subsidiary company measured at FVPL
Unquoted
Atul Bioscience Ltd
6% Cumulative Redeemable Preference shares
100
–
–
–
– 2,00,000
2.00
10% Cumulative Redeemable Preference shares
100
–
–
–
–
40,400
0.40
Subsidiary company measured at
amortised cost
1, 6
Unquoted
Amal Ltd (0% Redeemable Preference shares)
10 1,00,00,000
7.10 1,00,00,000
6.43 1,00,00,000
5.81
c) Investments in Government or Trust
securities measured at amortised cost
6 Years National Savings Certificates (deposited
with the Government departments)
88,000
– 0.01
– 0.01
– 0.01
d) Share application money
–
–
– 1.96
– 0.51
530.78
445.81
487.86
(
`
cr)
Particulars
Book value
As at
Market value
As at
March 31,
2017
March 31,
2016
April 01,
2015
March 31,
2017
March 31,
2016
April 01,
2015
Quoted
2
432.43
355.85
394.25
418.74
338.91
377.00
Unquoted
98.35
89.96
93.61
–
–
–
530.78
445.81
487.86
418.74
338.91
377.00
¹ Associate company up to November 30, 2016
2
includes equity component recognised from 0% finance provided to Amal Ltd
3
carrying value of
`
12,040 (March 31, 2016:
`
7,720 and April 01, 2015:
`
7,850)
4
Sale of Equity shares under the buy back offer
5
Under liquidation
6
Includes
`
1 cr due for redemption as on March 31, 2017
Refer Note 7.12 of Corporate Governance Report for details of Equity shares in unclaimed suspense account.
(
`
cr)
Note 6 Loans
As at
March 31, 2017
As at
March 31, 2016
As at
April 01, 2015
Current
Non-
current
Current
Non-
current
Current
Non-
current
a) Loan to subsidiary companies | associate
company (refer Note 27.4 and 27.13)
i)
Secured, considered good
0.59
7.01
–
6.41
–
5.41
ii) Unsecured, considered good
4.59
–
–
7.26
–
6.77
5.18
7.01
– 13.67
– 12.18
Notes
to the Financial Statements